Seroatlas · Human Serome Atlas

AMACR

Alpha-methylacyl-CoA racemase

Also known as: AMACR_HUMAN, P504S, RACE

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9UHK6
Gene
AMACR
Ensembl
ENSG00000242110
Chromosome
5
Canonical length
382 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Vesicles,Peroxisomes,Plasma membrane,Cytosol

OverviewNCBI Gene

This gene encodes a racemase. The encoded enzyme interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R)- and (S)-stereoisomers. The conversion to the (S)-stereoisomers is necessary for degradation of these substrates by peroxisomal beta-oxidation. Encoded proteins from this locus localize to both mitochondria and peroxisomes. Mutations in this gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy due to defects in bile acid synthesis. Alternatively spliced transcript variants have been described. Read-through transcription also exists between this gene and the upstream neighboring C1QTNF3 (C1q and tumor necrosis factor related protein 3) gene. [provided by RefSeq, Mar 2011]

Canonical amino-acid sequenceUniProt

382 residues, UniProt reviewed canonical sequence.

>Q9UHK6|AMACR
     1  MALQGISVVE LSGLAPGPFC AMVLADFGAR VVRVDRPGSR YDVSRLGRGK RSLVLDLKQP
    61  RGAAVLRRLC KRSDVLLEPF RRGVMEKLQL GPEILQRENP RLIYARLSGF GQSGSFCRLA
   121  GHDINYLALS GVLSKIGRSG ENPYAPLNLL ADFAGGGLMC ALGIIMALFD RTRTGKGQVI
   181  DANMVEGTAY LSSFLWKTQK LSLWEAPRGQ NMLDGGAPFY TTYRTADGEF MAVGAIEPQF
   241  YELLIKGLGL KSDELPNQMS MDDWPEMKKK FADVFAEKTK AEWCQIFDGT DACVTPVLTF
   301  EEVVHHDHNK ERGSFITSEE QDVSPRPAPL LLNTPAIPSF KRDPFIGEHT EEILEEFGFS
   361  REEIYQLNSD KIIESNKVKA SL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against AMACR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.28
Highest tissue expression
168 nTPM

Expression across tissuesHPA

Tissue

  • liver: 168 nTPM
  • kidney: 125 nTPM
  • salivary gland: 56 nTPM
  • rectum: 40 nTPM
  • colon: 37 nTPM
  • prostate: 36 nTPM

Single-cell type

  • hepatocytes: 25 nCPM
  • respiratory ionocytes: 15 nCPM
  • other brain neurons: 15 nCPM
  • bergmann glia: 14 nCPM
  • microglia: 14 nCPM
  • colonocytes: 12 nCPM

Immune cell

  • non-classical monocyte: 14 nTPM
  • neutrophil: 9 nTPM
  • eosinophil: 8.8 nTPM
  • myeloid DC: 8.6 nTPM
  • NK-cell: 8.4 nTPM
  • gdT-cell: 7.6 nTPM

Brain region

  • hypothalamus: 12 nTPM
  • pons: 9.8 nTPM
  • white matter: 9.2 nTPM
  • spinal cord: 8.9 nTPM
  • cerebral cortex: 8.8 nTPM
  • midbrain: 8.8 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about AMACR.

Disease | AllUniProt

Conditions AMACR is implicated in, by any mechanism.

Disease | GeneticClinVar

4 pathogenic / likely-pathogenic of 453 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.75
gnomAD pLI
0.03
gnomAD missense Z
0.56
DepMap mean gene effect
-0.02
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads AMACR as an antibody target. Whether an autoantibody or antibody against AMACR could matter depends on whether native AMACR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

AMACR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label AMACR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/AMACR. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...